These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34092412)

  • 1. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
    Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
    Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
    Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
    Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
    Wagner BE; Langstraat CL; McGree ME; Weaver AL; Sarangi S; Mokri B; Dowdy SC; Cliby WA; Kumar A; Bakkum-Gamez JN
    Gynecol Oncol; 2019 Feb; 152(2):286-292. PubMed ID: 30471900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
    Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
    Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.
    Mokri B; Mariani A; Heit JA; Weaver AL; McGree ME; Martin JR; Lemens MA; Cliby WA; Bakkum-Gamez JN
    Int J Gynecol Cancer; 2013 Nov; 23(9):1684-91. PubMed ID: 24172104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
    Manning-Geist BL; Alimena S; Del Carmen MG; Goodman A; Clark RM; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Gynecol Oncol; 2019 Apr; 153(1):63-67. PubMed ID: 30635213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
    Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
    Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
    Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
    Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Salinaro JR; McQuillen K; Stemple M; Boccaccio R; Ehrisman J; Lorenzo AM; Havrilesky L; Secord AA; Galvan Turner V; Moore KN; Davidson B
    Int J Gynecol Cancer; 2020 Apr; 30(4):491-497. PubMed ID: 32054646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of venous thromboembolism prophylaxis program in patients with colorectal cancer using the enhanced recovery after surgery protocol.
    Cho HJ; Lee IK; Lee YS; Yun SS; Park SC; Kim JY; Lee CS
    Eur J Surg Oncol; 2022 Jun; 48(6):1384-1389. PubMed ID: 35120818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
    PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Khan S; Kelly KJ; Veerapong J; Lowy AM; Baumgartner JM
    Ann Surg Oncol; 2019 Jul; 26(7):2276-2284. PubMed ID: 31065960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
    Shafa A; Watkins AB; McGree ME; Weroha SJ; Wahner Hendrickson AE; Block MS; Langstraat CL; McBane RD; Bakkum-Gamez JN; Kumar A
    Gynecol Oncol; 2023 Sep; 176():36-42. PubMed ID: 37442024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
    Klein DA; Mann AK; Freeman AH; Liao CI; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2020 Feb; 222(2):170.e1-170.e11. PubMed ID: 31421122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: A retrospective study.
    Oxley SG; Achampong YA; Sambandan N; Hughes DJ; Thomas M; Lockley M; Olaitan A
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2091-2096. PubMed ID: 34486103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance validation of the Mayo triage algorithm applied to individualize surgical management of advanced epithelial ovarian cancer.
    Jiang C; Li Z
    Gynecol Oncol; 2021 Aug; 162(2):339-344. PubMed ID: 34147283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study evaluating the impact of implementing the ERAS protocol on patients undergoing surgery for advanced ovarian cancer.
    Agarwal R; Rajanbabu A; P V N; Goel G; Madhusudanan L; U G U
    Int J Gynecol Cancer; 2019 Mar; 29(3):605-612. PubMed ID: 30833445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.